Cambridge Investment Research Advisors »

Cortexyme shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Cortexyme (QNCX) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Cortexyme

Tip: Access up to 7 years of quarterly data

All positions including Cortexyme held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cortexyme by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $25k 15k 1.64
2025-06-30 $25k 15k 1.64

More positions owned by Cambridge Investment Research Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple Inc Com (AAPL)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corp Com (MSFT)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
SPDR S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Meta Platforms Inc Cl A (META)
Vanguard Index Fds Growth Etf (VUG)
Spdr Series Trust Portfolio S&P500 (SPLG)

View all positions for Cambridge Investment Research Advisors

Top funds holding Cortexyme

Nantahala Capital Management
Vanguard Group
Millennium Management
Ieq Capital
ADAR1 Capital Management
Almitas Capital
Renaissance Technologies
Geode Capital Management
BlackRock
HighTower Advisors
Union Square Park Capital Management
Marshall Wace
State Street Corporation
Alphabet
Shay Capital

View all funds holding Cortexyme